午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
2016 CFDA approved 45 new medical devices
 
Author:中國銘鉉 企劃部  Release Time:2016-12-9 9:34:46  Number Browse:990
 

2016 CFDA approved 45 new medical devices

Source: China's inscription Xuan planning department release date: 2016-12-9 9:24:23 views: 2

Medical network on December 9 - following the November 15, the CFDA medical equipment technology evaluation center (hereinafter referred to as the "CMDE) published include hangzhou commitment medical treatment of sacral nerve stimulation system for a total of seven innovative medical devices to enter the special program, on November 22, CMDE again issued 2016 11th innovation medical instrument special approval to apply for review the results of the public, to agree to one application program to the innovation special approval process.

In this paper, the inventory by the end of this year on December 7, 2016, through the innovation of medical equipment in 2016 45 product special approval to apply for review; There are 2 companies (superscript) marked on each have 3 item, about the project of in vitro diagnostic (background for the green) a total of eight.

Note: minimally invasive avatar is a wholly owned subsidiary of Shanghai minimally invasive.

Attachment: nearly two years into the approved "innovation medical instrument special approval procedures" products

In 2015, a total of 29 item into the CFDA innovation medical instrument special approval to apply for review, including Shanghai minimally invasive 2 item, about the project of in vitro diagnostic (background for the green) a total of five.

Note: minimally invasive heart medical technology, a wholly owned subsidiary of Shanghai minimally invasive.

In 2014, a total of 17 products enter the CFDA innovation medical instrument special approval to apply for review, the first national health technology (shenzhen) co., LTD. Have 2 item, about the project of in vitro diagnostic (background for the green) a total of four.


 
Previous article:Guangdong medical consumables MSC centralized purchasing price plummeted 30%!
Next article:Inventory: 2016 pharmaceutical industry hot issues
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號